Issue 03-14-2016 Archives - Page 2 of 2 - CDR

Battle to build scale is now a global contest

March 14, 2016 by Jeffrey Woldt and Chain Drug Review Canadian pharmacy market, Jean Coutu Group, Jeffrey Woldt, Katz Group, Lawtons Drugs, Loblaw, McKesson, Rexall Health, Shoppers Drug Mart, Sobeys 2016, Issue 03-14-2016, Issues, Leading Headlines, Opinion

McKesson Corp.’s agreement to acquire Rexall Health from Katz Group is notable in several respects. The transaction alters the balance of power in the Canadian pharmacy market. In addition, it offers confirmation, if any were needed, of the relentless drive among major players in the sector to increase their scale and, in the process,

CVS recognized as retail health innovator

March 14, 2016 by David Pinto and Chain Drug Review CVS Health, David Pinto, Fast Company, Larry Merlo 2016, Issue 03-14-2016, Issues, Opinion

Fast Company, one of the more appealing and relevant business publications to have come along in recent years, recently compiled a list of the world’s 50 most innovative companies. Several familiar names were included, perhaps most notably to retail students, CVS Health. Not surprisingly, Fast Company presented a strong case for CVS’ inclusion, but it